Carregant...
Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence
A consolidated overview of evidence for the effectiveness and safety/tolerability of hepatic encephalopathy (HE) treatment over the long term is currently lacking. We identified and assessed published evidence for the long-term (≥6 months) pharmacological management of HE with lactulose and/or rifax...
Guardat en:
| Publicat a: | Eur J Gastroenterol Hepatol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams And Wilkins
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6416096/ https://ncbi.nlm.nih.gov/pubmed/30444745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MEG.0000000000001311 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|